According to this study in Investigative Ophthalmology and Visual Science: Purpose: Aim of the present randomized, double-blind, placebo-controlled clinical trial was to assess the efficacy and tolerability of 0.5% indomethacin eye drops in adult patients suffering from macular edema (ME) related to different aetiology uveitis. Methods:Forty-six eyes of thirty-one adult patients (20 females and 11 males) mean age 39 years, affected by inflammatory macular edema, were randomized to receive a dose of commercial 0.5% indomethacin eye-drops (INDOM®, Alfa Intes, Italy) four times a day (16 subjects = 23 eyes) or placebo (the vehicle of INDOM®, 15 subjects = 23 eyes) during a six months' active therapy follow-up. Study assessment at each visit included: visual acuity testing (VA), slit lamp examination, intra ocular pressure (IOP) evaluation and Heidelberg Spectralis Optical Coherence Tomography (OCT) central foveal thickness (CFT) measurement. Any variation in subjective symptoms and...